Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

PHASE2RecruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2029

Conditions
Graft Vs Host DiseaseVitamin A DeficiencyVitamin D Deficiency
Interventions
DRUG

Vitamin A

Enrolled subjects will receive one observed oral vitamin A dose, prior to their HSCT, in the outpatient clinic or inpatient Bone Marrow Transplant (BMT) floor.

OTHER

Placebo

Placebo pills containing microcrystalline cellulose will be dispensed in patients who are randomized to the placebo arm.

Trial Locations (3)

14203

RECRUITING

Roswell Park Comprehensive Cancer Center, Buffalo

33612

RECRUITING

Moffitt Cancer Center, Tampa

43210

RECRUITING

The Ohio State University, Columbus

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER